John C. McLenithan

5.0k citations

39 papers · 3.6k indexed · 3 hit papers · h-index 23

Epidemiology top 2%
Molecular Biology top 5%
Physiology top 2%
Cardiology and Cardiovascular Medicine top 2%
Surgery top 5%

Co-authors: Alan R. Shuldiner Susan K. Fried M. Daniel Lane Mi‐Jeong Lee Da‐Wei Gong Toni I. Pollin Rongze Yang Hong Hu
Topics: Adipose Tissue and Metabolism (16 papers)Metabolism, Diabetes, and Cancer (9 papers)Adipokines, Inflammation, and Metabolic Diseases (7 papers)
Cited by: Physiology Biochemistry Epidemiology
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Germany China

In The Last Decade

John C. McLenithan

39 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

2006 715 citations Rongze Yang, Alan R. Shuldiner et al. profile →
Omentin Plasma Levels and Gene Expression Are Decreased in Obesity

2007 617 citations Susan K. Fried, Alan R. Shuldiner et al. Diabetes profile →
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

2008 517 citations Toni I. Pollin, Coleen Damcott et al. Science profile →

Peers

Countries citing papers authored by John C. McLenithan

Since Specialization

Citations

This map shows the geographic impact of John C. McLenithan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. McLenithan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. McLenithan more than expected).

Fields of papers citing papers by John C. McLenithan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. McLenithan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. McLenithan. The network helps show where John C. McLenithan may publish in the future.

Co-authorship network of co-authors of John C. McLenithan

This figure shows the co-authorship network connecting the top 25 collaborators of John C. McLenithan. A scholar is included among the top collaborators of John C. McLenithan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. McLenithan. John C. McLenithan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Eight-Day Point of Care CAR T-Cell Manufacturing on Clinimacs Prodigy from Healthy Donors As a Proof-of-Concept Study 2021 ·Blood ·Kim G. Hankey,Tim Luetkens,(unknown),John C. McLenithan,John M. Braxton,(unknown),(unknown),Rena G. Lapidus,(unknown),(unknown),Jean A. Yared,Nancy M. Hardy,Ulrike Mock,(unknown),(unknown),Xiaoxuan Fan,Djordje Atanackovic,Aaron P. Rapoport,Saurabh Dahiya	1
2	μ-Crystallin in Mouse Skeletal Muscle Promotes a Shift from Glycolytic toward Oxidative Metabolism 2021 ·SHILAP Revista de lepidopterología ·(unknown),Andrea O’Neill,(unknown),Weiliang Huang,Joaquin M. Muriel,Valeriy Lukyanenko,Maureen A. Kane,Christopher W. Ward,(unknown),Joseph A. Roche,John C. McLenithan,(unknown),Robert J. Bloch	2
3	A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics 2016 ·EBioMedicine ·(unknown),Yaqin Zhang,Li Liu,Kseniya Golovnina,(unknown),Thomas O. Eichmann,Madhu Lal‐Nag,Urmila Sreenivasan,John C. McLenithan,Slava Ziegler,Carole Sztalryd,Achim Lass,Douglas S. Auld,Brian Oliver,Herbert Waldmann,Zhuyin Li,Min Shen,Matthew B. Boxer,Mathias Beller	11
4	A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors 2015 ·Endocrine Related Cancer ·(unknown),(unknown),Olga Goloubeva,John C. McLenithan,Gauri Sabnis	14
5	Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes 2014 ·New England Journal of Medicine ·(unknown),Laura M. Yerges‐Armstrong,Richard B. Horenstein,Toni I. Pollin,Urmila Sreenivasan,(unknown),William S. Blaner,Søren Snitker,Jeffrey R. O’Connell,(unknown),Richard J. Breyer,Alice S. Ryan,John C. McLenithan,Alan R. Shuldiner,Carole Sztalryd,Coleen Damcott	151
6	Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells 2014 ·Microvascular Research ·(unknown),(unknown),Brandon Cooper,John C. McLenithan,(unknown),(unknown),Jack L. Arbiser,(unknown),Alexander R. Moise,Jackob Moskovitz,Antonino Passaniti	19
7	Aerobic Exercise Plus Weight Loss Improves Insulin Sensitivity and Increases Skeletal Muscle Glycogen Synthase Activity in Older Men 2013 ·The Journals of Gerontology Series A ·A. S. Ryan,Leslie I. Katzel,Steven J. Prior,John C. McLenithan,Andrew P. Goldberg,Heidi K. Ortmeyer	18
8	Determinants of intrathoracic adipose tissue volume and associations with cardiovascular disease risk factors in Amish 2013 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown),Wendy S. Post,John C. McLenithan,Michael L. Terrin,Laurence S. Magder,Irfan Zeb,Matthew J. Budoff,Braxton D. Mitchell	4
9	N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in Vivo 2011 ·Journal of Biological Chemistry ·Kavita Bhalla,Bor Jang Hwang,Jang Hyun Choi,Ruby Dewi,Lihui Ou,John C. McLenithan,William Twaddel,Edwin Pozharski,Jeffry B. Stock,Geoffrey D. Girnun	27
10	A common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitro 2010 ·Bone ·Nicole L. Hoppman,John C. McLenithan,Daniel J. McBride,Haiqing Shen,Jan Bruder,Richard L. Bauer,John R. Shaffer,Jie Liu,Elizabeth A. Streeten,Alan R. Shuldiner,Candace M. Kammerer,Braxton D. Mitchell	7
11	Glucokinase regulatory protein gene polymorphism affects postprandial lipemic response in a dietary intervention study 2009 ·Human Genetics ·Haiqing Shen,Toni I. Pollin,Coleen Damcott,John C. McLenithan,Braxton D. Mitchell,Alan R. Shuldiner	20
12	A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotectionbreakdown → 2008 ·Science ·Toni I. Pollin,Coleen Damcott,Haiqing Shen,Sandra Ott,John C. Shelton,Richard B. Horenstein,Wendy S. Post,John C. McLenithan,Lawrence F. Bielak,Patricia A. Peyser,Braxton D. Mitchell,Michael Miller,Jeffrey R. O’Connell,Alan R. Shuldiner	517
13	Consequences of Lipid Droplet Coat Protein Downregulation in Liver Cells 2008 ·Diabetes ·(unknown),Hong Wang,Hui Chen,John C. McLenithan,Da‐Wei Gong,(unknown),Daozhan Yu,Susan K. Fried,Michael J. Quon,Constantine Londos,Carole Sztalryd	165
14	DNA sequence variation in the promoter region of theVEGFgene impactsVEGFgene expression and maximal oxygen consumption 2005 ·American Journal of Physiology-Heart and Circulatory Physiology ·Steven J. Prior,James M. Hagberg,Chad M. Paton,Larry W. Douglass,Michael D. Brown,John C. McLenithan,Stephen M. Roth	87
15	Comparative studies of resistin expression and phylogenomics in human and mouse 2003 ·Biochemical and Biophysical Research Communications ·Rongze Yang,Qing Huang,(unknown),John C. McLenithan,(unknown),Alan R. Shuldiner,Serhan Alkan,Da‐Wei Gong	174
16	Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity 2001 ·Journal of Molecular Endocrinology ·(unknown),Hongxiang Hui,Karim Chamie,Stefan Binder,Michael Seibert,John C. McLenithan,Kristi D. Silver,(unknown)	28
17	Derepression of the C/EBPα gene during adipogenesis: Identification of AP-2α as a repressor 1998 ·Proceedings of the National Academy of Sciences ·Man‐Shiow Jiang,Qi‐Qun Tang,John C. McLenithan,(unknown),Wendy Shillinglaw,William J. Henzel,M. Daniel Lane	76
18	Surfaces of murine lymphocyte subsets differ in sialylation states and antigen distribution of a major N-linked penultimate saccharide structure 1990 ·Cellular Immunology ·Sidney W. Whiteheart,John C. McLenithan,Gerald W. Hart	25
19	Isozyme selective arylation of cytosolic glutathione S-transferase by [14C]bromobenzene metabolites 1988 ·Biochemical Pharmacology ·Yoko Aniya,John C. McLenithan,M.W. Anders	10
20	Purification and characterization of S-phenacylglutathione reductase from rat liver. 1985 ·Journal of Biological Chemistry ·(unknown),John C. McLenithan,M. W. Anders	6

About John C. McLenithan

John C. McLenithan is a scholar working on Biochemistry, Physiology and Cell Biology, having authored 39 papers that have together received 3.6k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (16 papers), Metabolism, Diabetes, and Cancer (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Physiology (1.3k citations), Biochemistry (292 citations) and Epidemiology (1.4k citations). John C. McLenithan has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Alan R. Shuldiner, Susan K. Fried, M. Daniel Lane, Mi‐Jeong Lee, Da‐Wei Gong, Toni I. Pollin, Rongze Yang, Hong Hu, Barbara C. Hansen and Haibin Wu. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact